Apollomics Competitors and Similar CompaniesClear all

Apollomics's competitors and similar companies include Marker Therapeutics and Esperance Pharmaceuticals.
Apollomics
Apollomics
Apollomics (formerly known as CBT Pharmaceuticals) is a biopharmaceutical company committed to developing medicines targeting the growth and proliferation of cancer cells.
Marker Therapeutics
Marker Therapeutics
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
Esperance Pharmaceuticals
Esperance Pharmaceuticals
Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs.
Founding Date
Founding Date
2015
Founding Date
2018
Founding Date
2006
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Foster City, US HQ
Southbank, AU
Hangzhou, CN
Shanghai, CN
Locations
Houston, US HQ
Locations
Houston, US HQ
Employees
Employees
1371% decrease
Employees
888% decrease
Employees
8
Valuation ($)
Valuation ($)
14.6 m
Valuation ($)
36.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$8.5m (FY, 2025)
Revenue (est.)
$3.5m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
($10.9m) (FY, 2025)
Net income
($12.2m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 238.8m
Total funding raised
N/A
Total funding raised
$ 28.7m
For sources of this data, please see the company profile

View Company Profiles

Marker Therapeutics
HQ
Houston, US
Employees
8

Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.

View company
Esperance Pharmaceuticals
HQ
Houston, US
Employees
8

Esperance Pharmaceuticals is a company developing a class of targeted anticancer drugs.

View company